High Cut-off Hemodialysis Combined with Bortezomib-Based Therapy in Multiple Myeloma Patients with Severe Renal Impairment

被引:0
|
作者
Baertsch, Marc-A. [1 ]
Raab, Marc S. [2 ]
Beimler, Joerg [3 ]
Meissner, Julia [3 ]
Schmier, Johann [3 ]
Goldschmidt, Hartmut [1 ]
Hillengass, Jens [1 ]
机构
[1] Univ Hosp Heidelberg, Heidelberg, Baden Wurttembe, Germany
[2] Univ Clin Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[3] Heidelberg Univ, Heidelberg, Germany
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词
D O I
10.1016/j.clml.2017.03.218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS-216
引用
收藏
页码:E120 / E120
页数:1
相关论文
共 50 条
  • [1] Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Santostefano, Marisa
    De Sanctis, Lucia Barbara
    Tacchetti, Paola
    Mancini, Elena
    Pantani, Lucia
    Brioli, Annamaria
    Rizzo, Raffaella
    Mancuso, Katia
    Rocchi, Serena
    Pezzi, Annalisa
    Borsi, Enrica
    Terragna, Carolina
    Marzocchi, Giulia
    Santoro, Antonio
    Cavo, Michele
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 647 - 652
  • [2] High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy
    Sinisalo, Marjatta
    Silvennoinen, Raija
    Wirta, Ole
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (06) : 640 - 640
  • [3] Combined chemotherapy and high cut-off hemodialysis improve outcomes in, multiple myeloma patients with severe renal failure
    Hutchison, Colin A.
    Cook, Mark
    Basu, Supratik
    Cockwell, Paul
    Basnayake, Kolitha
    Bradwell, Arthur
    [J]. BLOOD, 2007, 110 (11) : 1056A - 1056A
  • [4] Superior myeloma response with bortezomib-based regimen in multiple myeloma patients with renal impairment
    Bao, Li
    Lu, Jin
    Wang, Shihua
    Huang, Xiaojun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6200 - 6209
  • [5] Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury
    Steiner, N.
    Abdel Hamid, A.
    Kronbichler, A.
    Neuwirt, H.
    Myslivecek, M.
    Kollar, M.
    Lachmanova, J.
    Rysava, R.
    Hruskova, Z.
    Spicka, I.
    Willenbacher, W.
    Nachbaur, D.
    Wolf, D.
    Tesar, V.
    Gunsilius, E.
    [J]. JOURNAL OF NEPHROLOGY, 2021, 34 (04) : 1263 - 1270
  • [6] Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury
    N. Steiner
    A. Abdel Hamid
    A. Kronbichler
    H. Neuwirt
    M. Myslivecek
    M. Kollar
    J. Lachmanova
    R. Rysava
    Z. Hruskova
    I. Spicka
    W. Willenbacher
    D. Nachbaur
    D. Wolf
    V. Tesar
    E. Gunsilius
    [J]. Journal of Nephrology, 2021, 34 : 1263 - 1270
  • [7] HEMODIALYSIS WITH HIGH CUT-OFF FILTERS AND CHEMOTHERAPY FOR MULTIPLE MYELOMA PATIENTS WITH ACUTE RENAL FAILURE
    Alkadi, N.
    Dourdil, V.
    Bonafonte, E.
    Arango, L.
    Leza, D.
    Escobar, M. J.
    Romero, L. L.
    Olave, M. T.
    Palomera, L.
    [J]. HAEMATOLOGICA, 2014, 99 : 639 - 639
  • [8] BORTEZOMIB-BASED THERAPY IN FRAIL MULTIPLE MYELOMA PATIENTS
    Antonioli, E.
    Staderini, M.
    Nozzoli, C.
    Bacchiarri, F.
    Barone, F.
    Grieco, P.
    Coltro, G.
    Guarrera, A.
    Messeri, M.
    Bosi, A.
    [J]. HAEMATOLOGICA, 2017, 102 : 132 - 132
  • [9] Acute renal failure in patients with myeloma: Experience with extended high cut-off hemodialysis
    Isabel Saez, Maria
    Camarero, Vanesa
    Rosales, Alejandro
    Hijazi, Badawi
    Jesus Izquierdo, Maria
    Labrador, Jorge
    Alvarez, Rodolfo
    Hermida, Julio
    Mercado, Veronica
    Dolores Badia, Maria
    de Toro, Raquel
    Gonzalez, Basilia
    Abaigar, Pedro
    [J]. NEFROLOGIA, 2017, 37 (04): : 429 - 431
  • [10] Reversibility of Renal Impairment of Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Identification of Predictive Factors
    Dimopoulos, Meletios A.
    Roussou, Maria
    Kastritis, Efstathios
    Gavriatopoulou, Maria
    Zagouri, Flora
    Migkou, Magdalini
    Matsouka, Charis
    Barmparousi, Despina
    Christoulas, Dimitrios
    Psimenou, Erasmia
    Grapsa, Irini
    Terpos, Evangelos
    [J]. BLOOD, 2008, 112 (11) : 607 - 608